Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis
Arthritis & Rheumatology · 2025
DOI: 10.1002/art.43081 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Arthritis & Rheumatology, 2025. Verfasst von Yiming Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Irving Medical Center, New York City, New York. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary, Scleroderma, Systemic, Genetic Predisposition to Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, U.S. Department of Defense, Rheumatology Research Foundation.
Abstract (Originalsprache)
Objective
An increased risk of primary biliary cholangitis (PBC) has been reported in patients with systemic sclerosis (SSc). Our study aims to investigate the shared genetic susceptibility between the two disorders and to define candidate causal genes using cross‐phenotype genome‐wide association study (GWAS) meta‐analysis.
Methods
We performed cross‐phenotype GWAS meta‐analysis and Bayesian colocalization analysis for patients with SSc and patients with PBC. We performed both genome‐wide and locus‐based analysis, including tissue and pathway enrichment analyses, fine‐mapping, Bayesian colocalization analyses with expression quantitative trait loci and protein quantitative trait loci (pQTL) datasets, and phenome‐wide association studies. Finally, we used an integrative approach to prioritize candidate causal genes from the novel loci.
Results
We detected a strong genetic correlation between SSc and PBC (global genetic correlation = 0.84, P = 1.7 × 10 −6 ). In the cross‐phenotype GWAS meta‐analysis, we identified 44 nonhuman leukocyte antigens loci that reached genome‐wide significance ( P < 5 × 10 −8 ). Evidence of shared causal variants between patients with SSc and patients with PBC was found for nine loci, five of which were novel. Integrating multiple sources of evidence, we prioritized CD40 , ERAP1 , PLD4 , SPPL3 , and CCDC113 as novel candidate causal genes. The CD40 risk locus colocalized with trans‐pQTLs of multiple plasma proteins involved in B cell function.
Conclusion
Our study supports a strong shared genetic susceptibility between SSc and PBC. Using cross‐phenotype analyses, we have prioritized several novel candidate causal genes and pathways for these disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Columbia University Irving Medical Center, New York City, New York.
- National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
ORCID-Profile: Pravitt Gourh
Förderung
- NIDDK NIH HHS
- U.S. Department of Defense
- Rheumatology Research Foundation
- NIAMS NIH HHS
- NHLBI NIH HHS
- NHGRI NIH HHS
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Luo, Y., Khan, A., Liu, L., Lee, C. H., Perreault, G. J., Pomenti, S. F., Gourh, P., Kiryluk, K., & Bernstein, E. J. (2025). Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis. Arthritis & Rheumatology. https://doi.org/10.1002/art.43081
Vancouver
Luo Y, Khan A, Liu L, Lee CH, Perreault GJ, Pomenti SF, et al. Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis. Arthritis & Rheumatology. 2025. doi:10.1002/art.43081
BibTeX
@article{Luo2025,
author = {Luo, Yiming and Khan, Atlas and Liu, Lili and Lee, Cue Hyunkyu and Perreault, Gabriel J and Pomenti, Sydney F and Gourh, Pravitt and Kiryluk, Krzysztof and Bernstein, Elana J},
title = {Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis},
journal = {Arthritis & Rheumatology},
year = {2025},
doi = {10.1002/art.43081}
}
EUVIMED